ISABEL
CASTREJÓN FERNÁNDEZ
Profesora asociada de Ciencias de la Salud
Hospital Clínico San Carlos de Madrid
Madrid, EspañaPublications in collaboration with researchers from Hospital Clínico San Carlos de Madrid (9)
2023
-
Screening criteria for interstitial lung disease associated to rheumatoid arthritis: Expert proposal based on Delphi methodology
Reumatologia Clinica, Vol. 19, Núm. 2, pp. 74-81
2022
-
SER-SEPAR recommendations for the management of rheumatoid arthritis-related interstitial lung disease. Part 1: Epidemiology, risk factors and prognosis
Reumatologia Clinica, Vol. 18, Núm. 8, pp. 443-452
-
SER-SEPAR recommendations for the the management of rheumatoid arthritis-related interstitial lung disease. Part 2: Treatment
Reumatologia Clinica, Vol. 18, Núm. 9, pp. 501-512
2021
2020
-
Prevalence of hospital PCR-confirmed COVID-19 cases in patients with chronic inflammatory and autoimmune rheumatic diseases
Annals of the Rheumatic Diseases, Vol. 79, Núm. 9, pp. 1170-1173
2016
2015
-
Erratum to Safety of allopurinol compared with other urate-lowering drugs in patients with gout: a systematic review and meta-analysis (Rheumatol Int, (2015), 10.1007/s00296-014-3189-6)
Rheumatology International
-
Safety of allopurinol compared with other urate-lowering drugs in patients with gout: a systematic review and meta-analysis
Rheumatology International, Vol. 35, Núm. 7, pp. 1127-1137
2010
-
Estimated cutoff points for the 28-joint disease activity score based on C-reactive protein in a longitudinal register of early arthritis
Journal of Rheumatology, Vol. 37, Núm. 7, pp. 1439-1443